US Alzheimer Drug Pipeline Analysis

Published: October 2013
No. of Pages: 348
  

In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer's disease was 5.4 million in 2012. Out of this, the people aged 65 and above accounted for 5.2 million and at least 200,000 patients were younger than 65 with early?onset of Alzheimer's. It has been observed that almost 1 in 8 people coming under the 65+ age group are patients of Alzeimer's disease. Amongst the population in the 80+ age group, almost 45% have been detected with Alzeimer's disease.

There exists strong competition in the Azheimer's disease market in the US. Due to this, the market is open to new and savvy companies. Given that there is a continuous rise in the ageing population and an expected exponential increase in Alzheimer's disease cases, these new entrants have the opportunity to capture a major share in the market through their efficient therapies and drugs. Thus, a better understanding of the underlying biology by the new entrants would lead to many new branches of treatment in different stages of clinical testing.

"US Alzheimer Drug Pipeline Analysis" by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of Alzheimer disease. Research report covers all the ongoing drugs being developed in various development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Alzheimer drug market based upon development process.

Following parameters for each drug profile in development phase are covered in "US Alzheimer Drug Pipeline Analysis" research report:

  • Drug Profile Overview
  • Alternate Names for Drug
  • Active Indication
  • Phase of Development
  • Mechanism of Action
  • Brand Name
  • Patent Information
  • Country for Clinical Trial
  • Owner / Originator/ Licensee/Collaborator
  • Administrative Route
  • Drug Class
  • ATC Codes

US Alzheimer Drug Pipeline by Clinical Phase:

  • Research: 28
  • Preclinical: 106
  • Phase 0: 3
  • Phase-I: 36
  • Phase-I/II: 2
  • Phase-II: 25
  • Phase-II/III: 3
  • Phase-III: 8
  • Preregistration: 2
  • Marketed: 6

US Alzheimer Drug Pipeline Analysis

Table Of Contents

1. US Alzheimer Disease Market Overview

2. Alzheimer Drug Clinical Phase: Research
2.1 Overview
2.2 Alzheimer Drug Profile in Clinical Phase

3. Alzheimer Drug Clinical Phase: Preclinical
3.1 Overview
3.2 Alzheimer Drug Profile in Clinical Phase

4. Alzheimer Drug Clinical Phase: Phase 0
4.1 Overview
4.2 Alzheimer Drug Profile in Clinical Phase

5. Alzheimer Drug Clinical Phase: Phase I
5.1 Overview
5.2 Alzheimer Drug Profile in Clinical Phase

6. Alzheimer Drug Clinical Phase: Phase I/II
6.1 Overview
6.2 Alzheimer Drug Profile in Clinical Phase

7. Alzheimer Drug Clinical Phase: Phase II
7.1 Overview
7.2 Alzheimer Drug Profile in Clinical Phase

8. Alzheimer Drug Clinical Phase: Phase II/III
8.1 Overview
8.2 Alzheimer Drug Profile in Clinical Phase

9. Alzheimer Drug Clinical Phase: Phase III
9.1 Overview
9.2 Alzheimer Drug Profile in Clinical Phase

10. Alzheimer Drug Clinical Phase: Preregistration
10.1 Overview
10.2 Alzheimer Drug Profile in Clinical Phase

11. Marketed Alzheimer Drug
11.1 Overview
11.2 Marketed Alzheimer Drug Profile

List Of Tables and Figures

Each Drug Profile has Tables Representing Following Information:
Alternate Names
Originator & Owner
Collaborator
Technology Provider
Licensee
Highest Development Phase
Indications
Class
Mechanism of Action
ATC Code
Designated Brand Name

Published By: PNS Pharma
Product Code: PNS Pharma5


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 400,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100